Georgina Shaw
Papers
1
Total Citations
17
H-Index
1
About
Dr. Georgina Shaw is a pioneering researcher at the forefront of advanced therapeutic medicinal products (ATMPs) and automated cell manufacturing. Her work directly addresses a critical bottleneck in regenerative medicine: the costly, high-risk, and limited-scale manual production of clinical-grade cells. Dr. Shaw’s major contribution is the design of a fully integrated, “needle-to-needle” robot-assisted manufacturing platform, a breakthrough detailed in her highly cited 2022 paper (17 citations). This system automates the entire cell therapy workflow—from raw material to final product—ensuring compliance with Good Manufacturing Practice (GMP) standards while dramatically increasing production volume and consistency. By replacing manual expansion processes with a closed, robotic system, her research promises to lower costs, reduce contamination risks, and make life-saving cell therapies more accessible. Dr. Shaw’s work is a cornerstone in the field, positioning her as a key innovator translating complex biological therapies from the lab bench to scalable, clinical reality.
Research Focus
Key Achievements
Top Papers
- 1